Well-designed GWASs and large replication studies are still needed to identify reliable genetic variants of disease susceptibility and treatment response of patients with CH.
Eleonora Staines-Urias, María Carolina Páez, Pat Doyle, Frank Dudbridge, Norma C. Serrano, John P A Ioannidis, Brendan J. Keating, Aroon D. Hingorani, Juan P. Casas
Foteini Chatzinasiou, Christina M. Lill, Katerina Kypreou, Irene Stefanaki, V. Nicolaou, George M. Spyrou, Εvangelos Εvangelou, Johannes T. Roehr, Elisavet Kodela, A Katsambas, Hensin Tsao, John P A Ioannidis, Lars Bertram, A. Stratigos
Rufus Cartwright, Altaf Mangera, Kari A.O. Tikkinen, Prabhakar Rajan, Jori S. Pesonen, Anna C. Kirby, Ganesh Thiagamoorthy, Chris Ambrose, Juan Gonzalez‐Maffe, Phillip R. Bennett, Tom Palmer, Andrew J. Walley, Paul M Ridker, Vik Khullar, Christopher R. Chapple
Discussion(0)
No comments yet. Be the first to comment.